Results
1
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
1 companies
Cannara Biotech
Market Cap: CA$158.2m
Engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada.
LOVE
CA$1.72
7D
-9.0%
1Y
160.6%